Monthly Communication Report

Corporation:	AbbVie Corporation
Associated registration:	963671-15270-48
Communication date:	2026-04-30
Posted date:	2026-05-15

Designated Public Office Holders who participated in the communication:	Ritu Banerjee, Assistant Deputy Minister Health Emergency Readiness Canada, Innovation, Science and Economic Development Canada (ISED)
List of Details Subject matter Detail Health, Industry, Intellectual Property, International Trade Communication regarding free trade agreements as they relate to the biopharmaceutical industry. Health Communications regarding the value assessment of new medicines by Canada's Drug Agency (CDA) and the design of proposed new work streams, insofar as the federal government is a funder and holds a seat on the Board of Directors. Economic Development, Industry, Research and Development Innovation, Science and Economic Development (ISED)'s Health Emergency Readiness program, insofar as it pertains to growth and development of the life sciences industry in Canada. Economic Development, Health, Industry, Intellectual Property Patented Medicine Prices Review Board (PMPRB) Guidelines with regard to prices charged by Rights Holders for patented medicines sold in Canada. Health The pan Canadian Pharmaceutical Alliance (pCPA) with respect to public formulary listing of new medicines, insofar as the federal government is a participating jurisdiction and holds a seat on the Board of Directors.
Responsible Officer who filed this communication report:	Arima Ventin
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.